New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
April 18, 2024 08:00 ET
|
Noah Medical
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
Lung Cancer Screening Market To Reach USD 3.2 Billion By 2032
December 12, 2023 07:00 ET
|
DataHorizzon Research
Fort Collins, Colorado, Dec. 12, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, The Lung Cancer Screening Market size was valued at USD 1.4 Billion in 2022 and is expected to reach a...
Lung Cancer Screening Market to Hit USD 5.13 Billion by 2030 on Account of Rising Incidence of Lung Cancer and Advancements in Screening Technologies | Research by SNS Insider
September 26, 2023 08:52 ET
|
SNS Insider pvt ltd
Pune, Sept. 26, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that in 2022, the Lung Cancer Screening Market had a valuation of USD 2.81 billion. It is projected to achieve a value of...
8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners
July 06, 2023 10:08 ET
|
The Insight Partners
Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19 Impact and...
Hepatitis E Diagnostic Tests Market to Reach $93.5 Million by 2031: Says AMR
December 13, 2022 02:20 ET
|
Allied Market Research
Portland, OR, Dec. 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Hepatitis E Diagnostic Tests Market was estimated at $61.7 million in 2021 and...
Lung Cancer Screening Market to Reach USD 4.85 Billion by 2028; Medtronic Acquires Koninklijke Philips N.V to Bolster its Global Position: Fortune Business Insight™
August 30, 2021 05:45 ET
|
Fortune Business Insights
Pune, India, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The global lung cancer screening market size was USD 2.61 billion in 2020. The market is projected to grow from USD 2.80 billion in 2021 to USD 4.85...
VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018
April 12, 2018 13:46 ET
|
VisionGate, Inc.
SEATTLE, WA, April 12, 2018 (GLOBE NEWSWIRE) -- VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce that new lung cancer 3D cellular imaging...
Vital Further Streamlines Lung Screening Workflow with Support of Nuance PowerScribe® 360 and PenRad™ PenLung™
September 12, 2016 09:52 ET
|
Vital Images, Inc.
MINNEAPOLIS, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the support of Nuance...
Study finds 43 percent of patients undergoing lung cancer screening experience elevated levels of distress
October 19, 2015 18:04 ET
|
American College of Chest Physicians
GLENVIEW, Ill., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but...